What is the best pharmacologic treatment for sickle cell disease pain crises? (åpner nytt vindu)

Baker M, Hafner JW.

Kilde‎: Ann Emerg Med 2012;59(6):515-6.

Arkiv‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (åpner nytt vindu)

Update on pain management in sickle cell disease. (åpner nytt vindu)

Ballas SK.

Kilde‎: Hemoglobin 2011;35(5-6):520-9.

Arkiv‎: PubMed 21910604

DOI‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 (åpner nytt vindu)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (åpner nytt vindu)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Kilde‎: Thromb Haemost 2007;98(2):392-6.

Arkiv‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (åpner nytt vindu)

Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management. (åpner nytt vindu)

Tanabe P, Hafner JW, Martinovich Z, Artz N.

Kilde‎: Acad Emerg Med 2012;19(4):430-8.

Arkiv‎: PubMed 22506947

DOI‎: 10.1111/j.1553-2712.2012.01330.x

https://www.ncbi.nlm.nih.gov/pubmed/22506947 (åpner nytt vindu)

Management of sickle cell disease. (åpner nytt vindu)

de Montalembert M.

Kilde‎: BMJ 2008;337:a1397.

Arkiv‎: PubMed 18779222

https://www.ncbi.nlm.nih.gov/pubmed/18779222 (åpner nytt vindu)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (åpner nytt vindu)

Okomo U, Meremikwu MM.

Kilde‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Arkiv‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (åpner nytt vindu)

Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease. (åpner nytt vindu)

Ip H, Kesse-Adu R, Howard J, Hart N.

Kilde‎: Br J Haematol 2013;161(3):455-6.

Arkiv‎: PubMed 23419066

DOI‎: 10.1111/bjh.12254

https://www.ncbi.nlm.nih.gov/pubmed/23419066 (åpner nytt vindu)

Guidelines for the management of the acute painful crisis in sickle cell disease. (åpner nytt vindu)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Kilde‎: Br J Haematol 2003;120(5):744-52.

Arkiv‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (åpner nytt vindu)

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. (åpner nytt vindu)

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

Kilde‎: Diving Hyperb Med 2012;42(2):82-4.

Arkiv‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 (åpner nytt vindu)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (åpner nytt vindu)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Kilde‎: Hemoglobin 2004;28(2):85-102.

Arkiv‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (åpner nytt vindu)

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (åpner nytt vindu)

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

Kilde‎: N Engl J Med 1995;333(11):699-703.

Arkiv‎: PubMed 7637747

DOI‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 (åpner nytt vindu)

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (åpner nytt vindu)

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

Kilde‎: J Investig Med 2008;56(8):1023-7.

Arkiv‎: PubMed 19050460

DOI‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 (åpner nytt vindu)

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (åpner nytt vindu)

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

Kilde‎: N Engl J Med 2000;342(25):1855-65.

Arkiv‎: PubMed 10861320

DOI‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 (åpner nytt vindu)